| Browse All

ICON Public Limited Company (ICLR)

Healthcare | Diagnostics & Research | Dublin, Ireland | NasdaqGS
119.19 USD +3.61 (3.123%) ⇧ (April 17, 2026, 2:26 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 3:05 p.m. EDT

ICLR is currently in a volatile state, influenced by recent news about financial report delays and revenue recognition issues. Short-term traders may face challenges due to the bearish options activity and low momentum. Long-term investors should be cautious given the regulatory risks and the company's recent performance. There are no dividends to consider, making it less attractive for income-focused investors.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.499335
AutoETS0.502667
AutoARIMA0.502667
AutoTheta0.547453

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 47%
H-stat 1.42
Ljung-Box p 0.000
Jarque-Bera p 0.001
Excess Kurtosis 0.90
Attribute Value
Sector Healthcare
Debt to Equity Ratio 38.26
Revenue per Share 101.615
Market Cap 9,269,659,648
Trailing P/E 16.06
Forward P/E 9.71
Beta 1.28
Profit Margins 7.40%
Website https://www.iconplc.com

As of April 11, 2026, 3:05 p.m. EDT: Options activity shows mixed signals. Call options are heavily weighted on the downside with significant put volume, indicating potential bearish sentiment. High IV spikes on out-of-the-money strikes suggest speculation on volatility, possibly due to upcoming earnings reports or regulatory issues. The presence of major OI walls on the downside and ATM anchors suggests uncertainty and possible short-term price declines.


Info Dump

Attribute Value
52 Week Change -0.15776432
Address1 South County Business Park
Address2 Leopardstown
All Time High 347.72
All Time Low 2.5
Ask 149.76
Ask Size 2
Average Analyst Rating 2.1 - Buy
Average Daily Volume10 Day 832,470
Average Daily Volume3 Month 1,798,426
Average Volume 1,798,426
Average Volume10Days 832,470
Beta 1.283
Bid 86.52
Bid Size 2
Book Value 122.248
City Dublin
Compensation As Of Epoch Date 1,735,603,200
Country Ireland
Crypto Tradeable 0
Currency USD
Current Price 119.19
Current Ratio 1.059
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 120.95
Day Low 116.41
Debt To Equity 38.26
Earnings Call Timestamp End 1,761,220,800
Earnings Call Timestamp Start 1,761,220,800
Earnings Growth -0.987
Earnings Quarterly Growth -0.988
Earnings Timestamp End 1,776,715,200
Earnings Timestamp Start 1,776,715,200
Ebitda 1,522,180,992
Ebitda Margins 0.18786
Enterprise To Ebitda 7.836
Enterprise To Revenue 1.472
Enterprise Value 11,928,311,808
Eps Current Year 12.95392
Eps Forward 12.28032
Eps Trailing Twelve Months 7.42
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 353 1 247 6260
Fifty Day Average 109.3588
Fifty Day Average Change 9.8312
Fifty Day Average Change Percent 0.089898564
Fifty Two Week Change Percent -15.776432
Fifty Two Week High 211.0
Fifty Two Week High Change -91.81
Fifty Two Week High Change Percent -0.43511847
Fifty Two Week Low 66.57
Fifty Two Week Low Change 52.620003
Fifty Two Week Low Change Percent 0.79044616
Fifty Two Week Range 66.57 - 211.0
Financial Currency USD
First Trade Date Milliseconds 895,239,000,000
Float Shares 75,807,850
Forward Eps 12.28032
Forward P E 9.705773
Free Cashflow 925,353,856
Full Exchange Name NasdaqGS
Full Time Employees 39,800
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.28155002
Gross Profits 2,281,264,896
Has Pre Post Market Data 1
Held Percent Insiders 0.00667
Held Percent Institutions 1.12168
Implied Shares Outstanding 77,772,130
Industry Diagnostics & Research
Industry Disp Diagnostics & Research
Industry Key diagnostics-research
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,735,603,200
Last Split Date 1,218,585,600
Last Split Factor 2:1
Long Business Summary ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Long Name ICON Public Limited Company
Market us_market
Market Cap 9,269,659,648
Market State REGULAR
Max Age 86,400
Message Board Id finmb_397809
Most Recent Quarter 1,759,190,400
Net Income To Common 599,475,968
Next Fiscal Year End 1,767,139,200
Non Diluted Market Cap 8,822,626,543
Number Of Analyst Opinions 13
Open 116.98
Operating Cashflow 1,140,356,992
Operating Margins 0.12674
Payout Ratio 0.0
Peg Ratio 19.1291
Phone 353 1 291 2000
Previous Close 115.58
Price Eps Current Year 9.201076
Price Hint 2
Price To Book 0.9749853
Price To Sales Trailing12 Months 1.1440349
Profit Margins 0.07399
Quick Ratio 1.015
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.125
Region US
Regular Market Change 3.6100006
Regular Market Change Percent 3.1233783
Regular Market Day High 120.95
Regular Market Day Low 116.41
Regular Market Day Range 116.41 - 120.95
Regular Market Open 116.98
Regular Market Previous Close 115.58
Regular Market Price 119.19
Regular Market Time 1,776,450,371
Regular Market Volume 555,365
Return On Assets 0.04202
Return On Equity 0.06274
Revenue Growth 0.006
Revenue Per Share 101.615
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 76,359,932
Shares Percent Shares Out 0.0379
Shares Short 2,896,513
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 1,929,158
Short Name ICON plc
Short Percent Of Float 0.0382
Short Ratio 2.72
Source Interval 15
Symbol ICLR
Target High Price 180.0
Target Low Price 75.0
Target Mean Price 132.07692
Target Median Price 130.0
Total Cash 468,888,000
Total Cash Per Share 6.14
Total Debt 3,571,518,976
Total Revenue 8,102,602,240
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 7.42
Trailing P E 16.063343
Trailing Peg Ratio 19.1291
Triggerable 1
Two Hundred Day Average 158.2938
Two Hundred Day Average Change -39.10379
Two Hundred Day Average Change Percent -0.247033
Type Disp Equity
Volume 555,365
Website https://www.iconplc.com
Zip D18 X5R3